In 1994, the anaplastic lymphoma kinase (ALK), a receptor tyrosine kinase, was initially identified by Steve Morris through its involvement in the t(2;5)(p23;q35) chromosomal translocation associated with anaplastic large cell lymphoma (ALCL), a subset of T-cell lymphomas [1]. This evidence concerns the gene NTRK1 and anaplastic large cell lymphoma.